News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current TRVI market cap is 201M. The company's latest EPS is USD -0.3781 and P/E is -6.88.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.38M | -9.05M | -8.93M | -11.91M | -13.29M |
| Net Income | -7.15M | -7.7M | -7.82M | -10.9M | -12.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.65M | -32.49M | -32.48M | -29.91M | -33.92M |
| Net Income | -25.22M | -32.76M | -33.94M | -29.15M | -29.07M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 100.98M | 95.9M | 89.4M | 78.56M | 73.81M |
| Total Liabilities | 5.9M | 6.29M | 6.86M | 6.23M | 7.64M |
| Total Equity | 95.07M | 89.61M | 82.55M | 72.33M | 66.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 60M | 47.13M | 38.48M | 123.02M | 89.4M |
| Total Liabilities | 5.46M | 19.85M | 21.4M | 15.56M | 6.86M |
| Total Equity | 54.55M | 27.28M | 17.08M | 107.46M | 82.55M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.07M | -25.35M | -31.71M | -10.47M | -19.15M |
| Investing | 28.6M | 46.58M | 59.43M | -8.09M | -5.32M |
| Financing | -9.37M | -7.86M | -7.91M | -28k | 5.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.09M | -29M | -28.95M | -28.18M | -31.71M |
| Investing | -9k | -32k | N/A | -107.37M | 59.43M |
| Financing | 73.21M | 16.72M | 20.78M | 111.31M | -7.91M |
| Market Cap | 201M |
| Price to Earnings Ratio | -6.88 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.17 |
| Price to Book Ratio | 2.42 |
| Dividend Yield | - |
| Shares Outstanding | 76.87M |
| Average Volume (1 week) | 175.72k |
| Average Volume (1 Month) | 616.07k |
| 52 Week Change | 135.59% |
| 52 Week High | 4.00 |
| 52 Week Low | 1.00 |
| Spread (Intraday) | 0.01 (0.38%) |
| Company Name | Trevi Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.trevitherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
